What determines mortality in malignant pheochromocytoma? – Report of a case with eighteen-year survival and review of the literature
SUMMARY Pheochromocytoma (PCC) is a tumor derived from adrenomedullary chromaffin cells. Prognosis of malignant PCC is generally poor due to local recurrence or metastasis. We aim to report a case of malignant PCC with 18-year survival and discuss which factors may be related to mortality and long-t...
Main Authors: | Matheus de Oliveira Andrade, Vinícius Santos da Cunha, Dayana Carla de Oliveira, Olívia Laquis de Moraes, Adriana Lofrano-Porto |
---|---|
Format: | Article |
Language: | English |
Published: |
Brazilian Society of Endocrinology and Metabolism
|
Series: | Archives of Endocrinology and Metabolism |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972018000200264&lng=en&tlng=en |
Similar Items
-
Retroperitoneal Malignant Pheochromocytoma
by: Carlos Pérez Díaz, et al.
Published: (2019-05-01) -
Malignant pheochromocytoma with negative biochemical markers: Is it time to reclassify pheochromocytomas?
by: Shiva Borzouei, et al.
Published: (2019-05-01) -
Malignant Catatonia Mimicking Pheochromocytoma
by: Sophia Wong, et al.
Published: (2013-01-01) -
Prognostic Nomograms for Predicting Overall Survival and Cancer‐Specific Survival of Patients With Malignant Pheochromocytoma and Paraganglioma
by: Lei Zheng, et al.
Published: (2021-06-01) -
Surgical Treatment of Malignant Pheochromocytomas in Spine
by: Shu-Zhong Liu, et al.
Published: (2018-01-01)